Margaret Ewen
Datos Biográficos
| ID | 6992528 |
|---|---|
| NOMBRE | Margaret Ewen |
| NOMBRES | Margaret |
| APELLIDO | Ewen |
| FIRMA | EWEN M |
| AFILIACIONES | Health Action International |
| ORCID | 0000-0003-1177-4717 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 6 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 6 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2009 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases
Introduction Non-communicable diseases (NCDs) include cancers, cardiovascular diseases, diabetes, chronic respiratory disease and mental health
Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú
Objetive. Medir el precio, disponibilidad y asequibilidad de insulina y metformina, como comparador, en farmacias públicas y privadas en seis regiones del Perú. Métodos. Estudio transversal con uso de la metodología adaptada de la Organización Mundial de la Salud/Acción Internacional para la Salud (OMS/AIS). Se encuestaron farmacias públicas y privadas de seis regiones del Perú. Se recolectaron datos de disponibilidad y precio de insulina (todos …
Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases
The aim of this study was to evaluate the availability, price, and affordability of essential noncommunicable disease (NCD) medicines in Nepal. A cross-sectional survey was conducted in Nepal in 2015 using World Health Organization/Health Action International (WHO/HAI) methodology. We collected data on the availability and price of 60 essential NCD medicines from medicine distribution outlets in both the public and private health care sectors in …
Essential medicines for universal health coverage
Measuring medicine prices in Peru
The WHO/HAI survey approach strikes an appropriate balance between modest research costs and optimal information for policy. Focusing on commonly used medicines yields sufficient and valid results. Surveyors elsewhere should consider the limits of the survey data as well as any local circumstances, such as scarcity, that may call for extra field efforts
Medicine prices, availability, and affordability in 36 developing and middle-income countries
Sin obras prominentes en esta página.
Medicine prices, availability, and affordability in 36 developing and middle-income countries
Measuring medicine prices in Peru
The WHO/HAI survey approach strikes an appropriate balance between modest research costs and optimal information for policy. Focusing on commonly used medicines yields sufficient and valid results. Surveyors elsewhere should consider the limits of the survey data as well as any local circumstances, such as scarcity, that may call for extra field efforts
Essential medicines for universal health coverage
Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú
Objetive. Medir el precio, disponibilidad y asequibilidad de insulina y metformina, como comparador, en farmacias públicas y privadas en seis regiones del Perú. Métodos. Estudio transversal con uso de la metodología adaptada de la Organización Mundial de la Salud/Acción Internacional para la Salud (OMS/AIS). Se encuestaron farmacias públicas y privadas de seis regiones del Perú. Se recolectaron datos de disponibilidad y precio de insulina (todos …
Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases
The aim of this study was to evaluate the availability, price, and affordability of essential noncommunicable disease (NCD) medicines in Nepal. A cross-sectional survey was conducted in Nepal in 2015 using World Health Organization/Health Action International (WHO/HAI) methodology. We collected data on the availability and price of 60 essential NCD medicines from medicine distribution outlets in both the public and private health care sectors in …
Rethinking and redefining the definitions and how we measure availability and affordability of medicines and technologies for non-communicable diseases
Introduction Non-communicable diseases (NCDs) include cancers, cardiovascular diseases, diabetes, chronic respiratory disease and mental health
Business (6 obras) · Pharmaceutical Economics and Policy (6 obras) · Economics (5 obras) · Health Systems, Economic Evaluations, Quality of Life (4 obras) · Healthcare Systems and Reforms (4 obras) · Medicine (4 obras) · Economic growth (3 obras) · Environmental health (3 obras) · Developing country (2 obras) · Essential medicines (2 obras)